Ocular Therapeutix, Inc. (OCUL) vs Omnicell, Inc. (OMCL)
A side-by-side comparison of Ocular Therapeutix, Inc. and Omnicell, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OCUL
Ocular Therapeutix, Inc.
$7.41HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
OMCL
Omnicell, Inc.
$35.18HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — OCUL vs OMCL
growth of $100 · dividends reinvested · last 10yOCUL +12.9% (+1.2%/yr)OMCL -7.5% (-0.8%/yr)OCUL compounded faster over this window
OCUL OMCL
OCUL vs OMCL: by the numbers
- •OCUL is the larger company ($1.62B vs $1.60B market cap).
- •OMCL is profitable (3.13% net margin) while OCUL runs a net loss (-579.10%).
- •OCUL grew revenue faster over the past five years (10.03% vs 4.77% CAGR).
Metrics side by side
Valuation
| Metric | OCUL | OMCL |
|---|---|---|
| P/E ratio | N/A | 41.64 |
| Forward P/E | N/A | 15.51 |
| P/S ratio | 31.18 | 1.28 |
| P/B ratio | 3.12 | 1.24 |
| EV / EBITDA | N/A | 10.66 |
| FCF yield | N/A | 8.84% |
Profitability
| Metric | OCUL | OMCL |
|---|---|---|
| Gross margin | 87.11% | 44.77% |
| Operating margin | -521.04% | 4.73% |
| Net margin | -579.10% | 3.13% |
| ROE | -57.97% | 3.03% |
| ROIC | -50.20% | 2.43% |
Growth (annualized)
| Metric | OCUL | OMCL |
|---|---|---|
| Revenue CAGR (5Y) | 10.03% | 4.77% |
| EPS CAGR (5Y) | N/A | -43.29% |
| FCF CAGR (5Y) | N/A | -8.10% |
| Total return CAGR (5Y) | -5.73% | -26.44% |
Frequently asked
- Which has grown faster, OCUL or OMCL?
- Over the past five years, OCUL grew revenue faster — OCUL at a 10.03% CAGR versus OMCL at 4.77%.
- Is OCUL or OMCL more profitable?
- OMCL runs the higher net margin — OCUL at -579.10% versus OMCL at 3.13%.
- How have OCUL and OMCL total returns compared?
- Over the past 10 years, OCUL delivered 0.44% and OMCL delivered -0.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Omnicell P/E ratioOcular Therapeutix ROEOmnicell ROEOcular Therapeutix operating marginOmnicell operating marginOcular Therapeutix revenue growthOmnicell revenue growthOcular Therapeutix free cash flowOmnicell free cash flow
Ocular Therapeutix & Omnicell appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.